Insider Holders & Insider Ownership - CytomX Therapeutics Inc. (CTMX)

List of insiders holdings for CytomX Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
See Explanation of Responses
2024-02-14 10:09:536,702,889
0
6,702,889Form 13G
SHANNON TIMOTHY M
Director
2016-12-01 14:35:01448
3,244,381
3,244,829Form 4
Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT CO
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
Possible Member of 10% Group
10% Owner
2015-10-14 12:37:56946,024
0
946,024Form 13G
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner
2015-10-14 15:36:21749,055
0
749,055Form 4
McCarthy Sean A.
CEO
2024-03-28 19:12:49634,249
93,158
727,407Form 4
Goeltz II Robert C.
Chief Financial Officer
2017-05-16 16:57:43323,325
0
323,325Form 4
THIRD ROCK VENTURES LP
Third Rock Ventures GP L.P.
TRV GP LLC
LEVIN MARK J
STARR KEVIN P
TEPPER ROBERT I
10% Owner
2019-02-13 16:07:03227,653
0
227,653Form 13G
Chu Yu-Waye
Chief Medical Officer
2024-01-19 20:37:27223,750
0
223,750Form 4
Ogden Christopher
Chief Financial Officer
2024-06-14 16:24:33178,186
0
178,186Form 4
BELVIN MARCIA
SVP, Chief Scientific Officer
2024-03-21 16:37:36168,579
0
168,579Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
2020-02-19 18:41:18120,000
0
120,000Form 4
Landau Jeffrey B
Chief Business Officer
2024-03-21 16:36:46110,060
7680
117,740Form 4
ROWLAND LLOYD A
General Counsel
2024-03-21 16:41:27117,728
0
117,728Form 4
RAY DEBANJAN
Chief Financial Officer
2019-01-29 18:57:0990,000
0
90,000Form 4
HUMPHREY RACHEL
Chief Medical Officer
2019-01-29 19:00:0390,000
0
90,000Form 4
LADD CYNTHIA J
Senior VP and General Counsel
2017-01-27 13:52:1584,000
0
84,000Form 4
Peterson Amy C.
EVP, Chief Development Officer
2023-03-20 18:43:2658,433
0
58,433Form 4
Campoy Carlos
Chief Financial Officer
2023-03-20 18:43:3338,224
0
38,224Form 4
Young Matthew P.
Director
2024-05-17 17:36:1838,000
0
38,000Form 4
Su Zhen
Director
2024-05-17 17:36:0738,000
0
38,000Form 4
Ashworth Alan
Director
2024-05-17 17:31:0938,000
0
38,000Form 4
Gilbert Halley E
Director
2024-05-17 17:32:2538,000
0
38,000Form 4
Jones Elaine V
Director
2024-05-17 17:33:1438,000
0
38,000Form 4
Meyers James R
Director
2024-05-17 17:34:0238,000
0
38,000Form 4
Mohindru Mani
Director
2024-05-17 17:34:3838,000
0
38,000Form 4
Knifsend Robin
Principal Accounting Officer
2020-02-21 12:34:4334,000
0
34,000Form 4
HANNAH ALISON L.
Chief Medical Officer
2022-07-21 16:09:2531,898
0
31,898Form 4
GLUCK FREDERICK W
Director
2022-06-17 16:05:3825,000
0
25,000Form 4
SCARLETT JOHN A
Director
2021-06-17 18:46:3920,000
0
20,000Form 4
Fuchs Charles S.
Director
2020-06-17 17:06:4820,000
0
20,000Form 4
Huh Hoyoung
Director
2018-06-15 17:51:3614,000
0
14,000Form 4
McCourt Marion
Director
2017-06-22 13:58:1714,000
0
14,000Form 4
Exter Neil
Director
2017-06-22 13:56:5814,000
0
14,000Form 4
Canaan IX L.P.
Canaan Partners IX LLC
Director
2017-07-07 08:40:320
0
0Form 13G